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Exploiting big data for critical care research 
Introduction 
Over recent years the digitalisation of data collection and storage, in combination with advances in 
data science, has enabled the linkage and analysis of large datasets, or ‘big data’. The proposed 
benefits of these large linked databases to health are significant, with faster progress in improving 
health, better value for money and higher quality science. This is of particular benefit for critical care 
research where conditions are rare, heterogeneous, with high mortality rates and high loss to 
follow-up. However, there are limitations in using data to answer questions different from its 
original purpose. In addition to this, there are ethical concerns regarding the confidentiality and 
autonomy of the patients who contribute to these datasets. In this review we will firstly define big 
data, and then explore the main sources of data collection, consider the uses for big data, discuss 
the limitations and ethical concerns of using these large datasets, and finally consider scope for 
future projects. 
Definitions and sources of big data  
There is no specific definition for big data, but it is generally understood to refer to datasets whose 
size, complexity and dynamic nature are beyond the scope of traditional data collection and analysis. 
The size of collected data may be the size of a petabyte (1015 bytes), but more usefully can be 
classified into the five ‘V’s: volume, velocity, variety, veracity, and value1. These ‘V’s represent the 
vast volumes, the high-speed real-time data, and the variety of data types from unstructured text to 
physiological data, to imaging and genomic sequencing. The analysis of such complex data requires 
methods more familiar to the field of informatics than clinical research, such as machine learning 
and computational linguistics2. 
Healthcare registries and databases 
National critical care audit registries capture population-level critical care activity in participating 
hospitals with the primary aim of producing comparative risk adjusted outcomes in order to 
benchmark performance. The Intensive Care National Audit and Research Centre (ICNARC) has 
developed the Case Mix Programme, an audit of patient outcomes in England, Wales and Northern 
Ireland which contains 1.5 million patients and has formed the basis for clinical audit and research3. 
Other example registries include the Scottish Intensive Care Society Audit Group (SICSAG - Scotland)4 
and the Australian and New Zealand Intensive Care Society (ANZICS)5 databases.  
Health care databases maintained for administrative purposes, such as monitoring hospital activity 
or charging for health care provision, provide a rich source of data to identify patients requiring 
critical care or to link to critical care registries. In Scotland, all hospital discharges since 1981 are 
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recorded in the Scottish Morbidity Record 01 (SMR01) database with complete national coverage6. 
Through use of standardised national patient identifiers, this dataset is routinely linked to the 
SICSAG registry and death records.   
Electronic medical records 
Primary and secondary care records have become increasingly computerised in order to facilitate 
the coordination of healthcare professionals working across different sites. As such they are a 
detailed account of each individual patient’s interaction with the healthcare system. Data entry is 
increasingly standardised, facilitating linkage and research across different areas of healthcare. 
However unstructured ‘free text’ data can also be used for research purposes, and analysis 
techniques such as natural language processing (NLP) make this much more readily analysable7. 
There are several systems now in routine use in critical care that collate physiological data from 
bedside monitors, laboratory results, medical and nursing interventions and drug prescriptions onto 
a single electronic patient record8. These realtime data can be linked to other datasets to identify 
individual responses to interventions or physiological insults, increasing the accuracy of predictive 
models.  
Laboratory and genetic data 
There is a wealth of biomarker and imaging data that is collected as part of routine clinical care. 
Imaging analysis techniques have been developed that can automate data extraction, for example 
the detection of pulmonary emboli9, which can then be linked to other patient datasets. Whole 
genome sequencing, epigenetics and genome wide association studies have also produced vast 
quantities of data to add to individual patient analysis.  
Clinical trial data 
The number of randomised controlled trials conducted in critical care has grown substantially over 
the past decade10. Information is meticulously collected during these trials, often to answer a single 
research question, and at substantial expense. The concept of ‘open data’ has been promoted to 
encourage sharing of these datasets to enable secondary analysis. This could yield considerable 
benefits, particularly when datasets from multiple studies are pooled. Individual level meta-analysis 
of trials is a self-evident application of this approach11. Furthermore, exploiting pooled existing trial 
data to answer novel, epidemiological research questions can result in the generation of new 
knowledge. However, additional energy and expense may be required to harmonise datasets by 
mapping variables and outcomes across datasets to allow analyses to be undertaken. 
The TBI-IMPACT (International Mission for Prognosis and Analysis of Clinical Trials in Traumatic Brain 
Injury) project is an example of the step change in knowledge made possible through pooling clinical 
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trial data12. This international collaborative project pooled trials relating to traumatic brain injury in 
order to develop innovative methods to improve trial design and analysis, refine outcomes, and 
improve risk prediction. To date, the collaboration has published over 60 peer-reviewed articles.   
Examples of big data in critical care research 
The potential benefits of these large and near-complete datasets for research are significant. These 
data are collected routinely, and research results generated from these sources would be available 
more quickly and at considerably less expense than prospective studies. Big data can refine 
questions, generate hypotheses, and identify potential recruits for experimental studies. It can also 
estimate the sample size for studies more accurately by modelling estimated event rates and 
treatment effects based on large retrospective data. PCORnet (Patient Centred Outcomes Research 
net) is an initiative to combine electronic health records and other electronic sources of very large 
populations, with patient-researcher partnerships13. Patients will have an active role by generating 
questions, sharing data, volunteering for interventional trials, and interpreting and disseminating 
results.  
Genomics 
Genome wide association studies compare the genetic variation of patients with the disease or trait 
(cases) and patients without (controls). Research in critical care genomics has demonstrated that 
human susceptibility to infection is strongly heritable14. Rautenan et al recently identified common 
variants in the FER (Fps/Fes related tyrosine kinase) gene that associate with a reduced risk of death 
from sepsis due to pneumonia15. This could enable us to tailor interventions based on the likelihood 
of individual patient response. 
Health services research and audit 
The increasing complexities of therapy available to us in critical care have been accompanied by 
increasing expenses, and it is important to justify these costs in terms of outcomes and efficiencies. 
Analysis of national and international critical care registries have enabled validation of advanced ICU 
scoring systems, prediction of diagnostic outcomes, decision support, and comparative analyses for 
the contributing hospital3.  
The Multiparameter Intelligent Monitoring in Intensive Care II (MIMIC-II) database consists of 25,328 
intensive care unit stays16. It has collected clinical data, pooled from intensive care information 
systems and hospital archives, and high resolution physiological data (waveforms and time series of 
derived physiological measurements) obtained from bedside monitors. This has been de-identified 
for use as a freely accessible database for healthcare researchers. 
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Quality improvement 
The Mayo Clinic is conducting a trial in Critical Care using ProCCESs AWARE - Patient Centered Cloud-
based Electronic System: Ambient Warning and Response Evaluation17. This quality improvement 
tool combines electronic medical records, medical informatics and warning systems derived from 
data on previous patients. It will monitor adherence to best practice (eg appropriate shock 
resuscitation, appropriate sepsis treatment), and collect patient outcomes such as length of 
intensive care unit stay, and healthcare utilisation.  
It is also possible to use these data streams in real time to detect adverse events: Thommandram et 
al describe the use of real time data to detect, analyse and classify neonatal cardiorespiratory spells, 
thus shortening the time to diagnosis18. 
Public health 
Large datasets can identify disease patterns with the hope of targeting interventions at an earlier 
stage. Social media has been used with varying success in defining the geographical and temporal 
course of disease outbreaks, real-time tracking of harmful and infectious diseases, and increasing 
the knowledge of global distribution for various diseases19,20. 
Limitations 
Having more data to analyse does not obviate the need to apply epidemiological conceptual 
reasoning coupled with a careful approach to study design. Chance, error, bias and confounding- 
fundamental concepts in epidemiology - must be considered in the design and analysis of all 
observational studies. In fact, analyses using big data may amplify these limitations through the false 
security of producing highly precise results with narrow confidence limits.   
Chance 
Big data should reduce the risk false negative results arising from analyses - a typical limitation of 
small, prospective studies. However, false positive results may be more likely to occur due to testing 
of multiple hypotheses and the ability to analyse numerous subgroups (‘data dredging’). Study 
registration and protocol publication a priori may reduce the risk of publication of spurious study 
results21.  
Error 
Big data are usually collected for a purpose other than research. This means data can be 
compromised with respect to quality, accuracy, completeness, and accessibility (measurement 
error). Data science methods and machine learning algorithms are often employed to help make 
detect data signals amidst the background noise of messy data, but they cannot reliably remedy 
other data quality issues, particularly if researchers have a poor grasp of the nature of these 
limitations. The National Hip Fracture Database (NHFD) in England was mistakenly thought to 
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contain 65,535 patients – this was in fact the maximum number of rows that could be processed by 
older versions of Microsoft Excel22.   
Bias and confounding 
Of the numerous biases that can operate in observational studies, selection bias is of particular 
importance. The assumption that big data are representative of the target population to which 
results are generalised needs to be carefully assessed when relying on data generated through 
routine internet usage or social media. Studies using this population may exclude older individuals 
and those from poorer backgrounds – the very population groups usually over-represented in critical 
care. 
A common pitfall of epidemiological analyses is the assumption that a correlation identified between 
two factors can be attributed to a causal relationship. The recent publicity surrounding ‘Google Flu 
Trends’ (GFT) highlighted this and other issues with big data analyses23. GFT used queries posed to 
Google search engine related to influenza, correlated with official influenza incidence estimates, to 
produce an algorithm which appeared to accurately predict influenza activity over a number of 
seasons20. However, the algorithm substantially overestimated influenza activity in 2012/2013 and 
subsequent seasons. This was in part attributable to the confounding effect of media attention on 
that season’s influenza outbreak, which influenced the public to search for influenza-related items 
for reasons other than being ill with influenza symptoms. This episode emphasises the need for an 
understanding of fundamental epidemiological concepts when analysing big data23.  
Ethical and legal issues 
When compared with the potential for harm in interventional trials in critical care, harm arising from 
research using big data is less obvious. However, there are two main ethical areas of concern: the 
potential for identifying individual patients and the invasion of privacy without consent. 
Research using fully anonymised big data is consistent with Article 8 of the Human Rights Act 1998: 
‘everyone has the right to respect for his private and family life’. However linked databases are 
pseudonymised – they contain personal confidential data that has been anonymised but has a 
residual risk of re-identification. Linkage across multiple datasets increases the risk of individual re-
identification, particularly for rare conditions. This may be of particular relevance in genome 
sequencing where patients who have traits associated with susceptibility to disease may have care 
rationed or withdrawn24.  
Insistence on formal consent for big data research could cause wider societal harm, as the 
participation bias which might arise could skew the data to such an extent as to make results 
inaccurate or meaningless25. In the specific context of prospective studies, concerns have been 
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highlighted regarding sharing datasets to enable secondary analysis. Usually, study participants 
consent for their data to be used for a single, specific purpose. Consent taken from individuals for 
future secondary uses of the data is unlikely to be truly informed – the original researcher taking 
consent is unlikely to know the nature of research to be carried out in the future. In order to 
promote responsible data sharing, two guidance documents have recently been published both of 
which provide a framework to meet these ethical concerns26,27. 
The ethical basis for accessing and using big data for research without consent depends on societal 
expectations relating to how data will be used. Public concerns often centre around the disclosure 
and subsequent misuse of information to employers or insurance companies28. Workshops aimed at 
public engagement for population databases have shown a broad level of support for secondary use 
of data for research28. The National Health Service (NHS) in England argues for assumed individual 
patient consent for research using pseudonymised data combined with public awareness campaigns, 
but with an ‘opt-out’ option available. This allows patients a choice, thereby respecting autonomy 
and privacy and countering accusations of paternalism.  
Safeguards are an essential component of maintaining data security and public confidence, and 
every organisation should put policies, procedures and systems in place to ensure confidentiality 
rules are followed29. In the UK, legislation allows for the imposition of heavy fines and ultimately 
prosecution for breaches of the law. In addition to legal scrutiny, it is essential that there is overview 
of research using big data by Institutional Review Boards or Research Ethics Committees. Use of 
accredited ‘safe-havens’ (restricted environments for the secure analysis of data), supported by 
robust protection and governance, is one method of maintaining public confidence in big data 
research30. Data are only made available to approved researchers once pseudonymisation has taken 
place and research proposals have been scrutinised for risks of disclosure.  
Future 
The use of big data in critical care research and clinical practice will continue to grow, driven by 
increasing availability of large clinical datasets, genetic databases, linkage to non-health care data 
and the flourishing collaborations with informatics experts and data scientists. The increasing use of 
social media as a healthcare tool means that interactions between patients, patient groups and 
clinicians can be integrated into research. Development of open source software, such as the 
statistical package ‘R’ (www.r-project.org), along with web-based interfaces for data entry which 
increase ease of adapting databases, will lead to data analysis becoming more accessible.  
The potential to combine big data with ‘small data’ such as those from the numerous randomised 
controlled trials in critical care raises the tantalising possibility of individualised medicine. At the very 
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least, these novel methods may help to identify more homogeneous subgroups for which 
treatments might not be effective or even harmful31. 
In order to move beyond the hyperbole surrounding big data, clinicians need to gain familiarity with 
the analytical techniques used by data scientists and, similarly, data scientists need to understand 
epidemiological concepts. Until then, clinicians and researchers should retain a healthy scepticism in 
the face of claims that big data circumvents the problems inherent in observational studies.  
Conclusion 
The critical care community are well placed to capitalise on the potential benefits of big data 
through the significant volumes of data collected from many sources. Big data will enable us to 
refine our descriptive and predictive analytics based on real data. Whilst not obviating the need for 
clinical trials, by defining questions more precisely and estimating more accurate sample sizes and 
event rates, it will enable us to improve their design.  As big data becomes increasingly mainstream, 
it will be important to safeguard issues such as data security, governance and confidentiality. Big 
data has the potential to improve medical care and reduce costs significantly, both by individualising 
medicine, and by bringing together multiple sources of data about each individual patient. 
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